TABLE 1.
PD without FOG (n = 40) | PD with FOG (n = 37) | p‐Value | |
---|---|---|---|
Sex (male/female) | 21/19 | 19/18 | .920 |
Age (years) | 60.83 ± 8.58 | 63.92 ± 10.52 | .160 |
Age at disease onset (years) | 56.05 ± 8.54 | 56.31 ± 10.93 | .907 |
Duration of disease (years) | 4.5 (2.0,5.0) | 7.0n(4.0,10.0) | <.001 |
Education level (years) | 7.08 ± 4.03 | 7.14 ± 3.77 | .112 |
H‐Y stage | 2.30 ± 0.62 | 3.18 ± 0.60 | <.001 |
Side of symptoms at disease onset | .232 | ||
Right | 13 (32.5) | 12 (32.4) | |
Left | 22 (55.0) | 15 (40.5) | |
Bilateral | 5 (12.5) | 10 (27.0) | |
Levodopa equivalent dose (mg) | 402.55 ± 171.10 | 545.9 ± 218.64 | .002 |
Tremor subscore | 8.85 ± 5.12 | 10.11 ± 6.45 | .344 |
Rigidity subscore | 5.78 ± 2.61 | 8.95 ± 3.37 | <.001 |
Bradykinesia subscore | 11.33 ± 5.36 | 17.08 ± 6.60 | <.001 |
PIGD subscore | 3.65 ± 2.17 | 5.86 ± 2.42 | <.001 |
UPDRS part I score | 4.33 ± 3.25 | 6.46 ± 3.91 | .011 |
UPDRS part II score | 12.70 ± 5.74 | 23.32 ± 8.50 | <.001 |
UPDRS part III score | 30.08 ± 12.41 | 41.57 ± 15.38 | .001 |
UPDRS part IV score | 3.15 ± 2.00 | 6.62 ± 4.17 | <.001 |
PDQ‐39 score | 43.68 ± 26.02 | 70.43 ± 32.44 | <.001 |
NMSS score | 65.43 ± 30.79 | 89.41 ± 34.46 | .002 |
MoCA score | 20.90 ± 6.20 | 19.14 ± 6.79 | .237 |
HAM‐A score | 12.33 ± 8.22 | 18.78 ± 9.34 | .002 |
HAMD score | 13.33 ± 9.59 | 20.71 ± 11.02 | .002 |
ESS score | 7.40 ± 5.95 | 10.89 ± 5.99 | .009 |
AHRS score | 19.08 ± 5.77 | 16.86 ± 8.64 | .188 |
RBD score | 28.53 ± 28.47 | 30.03 ± 24.39 | .805 |
SCPA‐AUT score | 31.80 ± 6.97 | 35.87 ± 9.88 | .039 |
NFOG‐Q score | ‐ | 21.35 ± 6.36 | ‐ |
Abbreviations: ESS, Epworth Sleepiness Scale; H‐Y stage, Hoehn‐Yahr stage; HAM‐A, Hamilton Anxiety Scale; HAMD, Hamilton Depression Scale; NMSS, nonmotor symptoms assessment scale; MoCA, Montreal Cognitive Assessment; PDQ‐39, Parkinson's disease questionnaires‐39; PIGD, postural instability gait difficulty; UPDRS, Unified Parkinson's Disease Rating Scale.